Because 27C3 and other identified agonistic antibodies do not cross-react with rabbit or rodent LCAT species, we were unable to evaluate the impact of these antibodies on atherosclerosis in these well established preclinical disease models. The gene discussed is LCAT; the disease is atherosclerosis.